SPT23 Antibody

Shipped with Ice Packs
In Stock

Description

SPT23 Gene Overview

SPT23 encodes a transcriptional regulator involved in unsaturated lipid acid (ULA) synthesis and cellular stress responses. Key findings include:

  • Thermal Tolerance: Deletion of spt23 increases yeast survival under heat stress, reduces UFA content in cell membranes, and alters transposon activity .

  • Transposon Interaction: SPT23 suppresses Ty transposons, which influence yeast adaptability .

  • Regulatory Pathways: SPT23 and its homolog mga2 regulate ole1, a gene encoding Δ9 fatty acid desaturase. This regulation impacts membrane fluidity and stress resistance .

Antibody Structure and Function

While no SPT23-specific antibody is documented, antibody frameworks are well-established:

  • General Structure: Antibodies are Y-shaped proteins with antigen-binding Fab regions and effector Fc regions .

  • Functional Classes:

    ClassDistributionFunction
    IgGBlood, tissuesNeutralizes pathogens, opsonization
    IgAMucosal surfacesAggregates antigens in secretions
    IgEMast cellsAllergic responses, anti-parasitic activity

Lipid Metabolism and Thermal Resistance

  • Membrane Composition: SPT23 deletion reduces total unsaturated lipid acids (TULA) by 15–20%, correlating with enhanced heat tolerance .

  • Gene Interaction Network:

    GeneRoleImpact of spt23 Deletion
    ole1Fatty acid desaturaseDownregulated, reducing UFA
    spt3SAGA complex memberUpregulated, linked to stress response
    erg1Ergosterol synthesisNo significant change

Transposon Activity

  • LTR-Amplicon Sequencing: spt23Δ strains show 30% lower transposon richness but 25% higher activity, suggesting dual regulatory roles .

Antibody Development Insights

Though SPT23 antibodies are not reported, methodologies for similar targets include:

  • Hybridoma Technology: Used for monoclonal antibodies like AK23 (anti-desmoglein 3) .

  • Western Blot Validation: Example protocols for detecting lipid-related proteins (e.g., SPTLC3) involve SDS-PAGE and HRP-conjugated secondary antibodies .

Future Directions

  • Antibody Potential: Developing SPT23 antibodies could elucidate its post-translational modifications or localization, leveraging techniques like immunofluorescence .

  • Therapeutic Targets: Studying SPT23’s role in lipid metabolism might inform treatments for metabolic disorders or heat-stress applications in industrial yeast strains .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPT23 antibody; YKL020C antibody; Protein SPT23 antibody
Target Names
SPT23
Uniprot No.

Target Background

Function
This antibody functions as a dosage-dependent suppressor of Ty-induced promoter mutations. Its suppression mechanism likely involves protein-protein interactions, as it lacks the typical motifs found in transcriptional activators or DNA binding proteins.
Gene References Into Functions
  1. A PXY motif within the carboxyl terminus of Spt23p and Mga2p facilitates a physical and functional interaction with the ubiquitin ligase Rsp5p. PMID: 15466864
  2. WW domains 2 and 3 of Rsp5p play overlapping roles in binding to the WW domain-binding site on Spt23p and Mga2p. PMID: 17719829
  3. Rsp5p, Spt23p, and Mga2p may contribute to the regulation of lipid homeostasis and lipid particle formation. PMID: 18771750
Database Links

KEGG: sce:YKL020C

STRING: 4932.YKL020C

Q&A

What is SPT23 and why is it important in studies requiring specific antibodies?

SPT23 is a critical transcriptional regulator in Saccharomyces cerevisiae (budding yeast) that functions as a key determinant of cellular thermal tolerance. Research has demonstrated that SPT23 regulates unsaturated lipid acid (ULA) content in cells, which significantly affects cellular thermal tolerance . Additionally, SPT23 serves as a Ty suppressor, meaning it can interact with transposons (Tys) that contribute to yeast's adaptive evolution .

SPT23's importance stems from its multifunctional role in:

  • Regulating the OLE1 gene, which encodes a Δ9 fatty acid desaturase

  • Acting as a chromatin-molding factor and global transcriptional regulator

  • Modulating transposon activity, with deletion strains showing lower richness and higher evenness in LTR distributions

  • Contributing to thermal resistance mechanisms, with experimental data showing that deletion strains demonstrate higher survival rates, biomass, and ethanol production under heat stress

Researchers studying stress response pathways, lipid metabolism, or transposon-mediated adaptation mechanisms benefit from SPT23-specific antibodies to track protein expression, localization, and functional status.

What forms of SPT23 protein exist and how do antibodies distinguish between them?

SPT23 exists in two primary forms that researchers need to differentiate:

SPT23 FormMolecular WeightCellular LocationFunction
Full-length (p120)120 kDaMembrane-associatedPrecursor protein
Processed (p90)90 kDaNuclearActive transcription factor

Antibody selection depends on experimental goals:

  • Antibodies targeting N-terminal domains can detect both forms

  • C-terminal-specific antibodies selectively recognize the full-length form

  • Processing-specific antibodies target the unique epitopes created during proteolytic processing

When designing immunodetection experiments, researchers should consider whether total SPT23 levels or the ratio between processed and unprocessed forms is most relevant to their research question.

What validation steps are essential when using a new SPT23 antibody?

Thorough validation of SPT23 antibodies is crucial for reliable experimental outcomes:

  • Genetic specificity confirmation: Test antibody reactivity in wild-type versus SPT23 deletion strains. A properly specific antibody will show signal in wild-type samples and no signal in deletion mutants.

  • Western blot molecular weight verification: Confirm detection of bands at expected molecular weights (120 kDa for full-length and 90 kDa for processed form).

  • Peptide competition assay: Pre-incubate antibody with excess of the immunizing peptide prior to immunodetection. Specific binding should be significantly reduced or eliminated.

  • Cross-reactivity assessment: Test for potential cross-reactivity with related proteins, particularly MGA2, which shares structural similarities with SPT23.

  • Expression correlation test: Compare antibody signal intensity with experimentally altered expression levels (overexpression and knockdown) to confirm proportional detection.

Systematic validation ensures experimental data reliability and facilitates accurate interpretation of results when studying SPT23 function.

How can SPT23 antibodies be used to investigate thermal tolerance mechanisms?

SPT23 antibodies serve as valuable tools for investigating thermal tolerance pathways in yeast. Research findings indicate that SPT23 plays a dual role in thermal tolerance through both direct transcriptional regulation and transposon-mediated mechanisms .

Advanced methodological approaches include:

  • Monitoring processing dynamics: Western blot analysis using SPT23 antibodies can track the conversion of p120 to p90 under different temperature conditions. Research demonstrates that SPT23 deletion strains show higher survival rates during heat stress compared to overexpression strains .

  • Chromatin immunoprecipitation (ChIP): Using SPT23 antibodies for ChIP followed by sequencing allows identification of genome-wide binding sites under normal and heat stress conditions. Importantly, research has established that the relative weight of SPT23's direct transcriptional influence versus transposon-induced effects is approximately 4:3 .

  • Protein-protein interaction studies: Immunoprecipitation with SPT23 antibodies can identify temperature-dependent changes in interaction partners.

Experimental design should include time-course analyses during heat shock, comparison of subcellular fractions, and correlation with changes in membrane lipid composition, as SPT23 deletion has been shown to affect total unsaturated lipid acid content in cell membranes .

How do SPT23 antibodies help investigate the protein's relationship with transposons?

SPT23's function as a Ty suppressor makes antibody-based approaches crucial for understanding transposon-mediated adaptive responses. Research has demonstrated that SPT23 deletion affects LTR distribution patterns, with deletion strains showing lower richness but higher evenness in LTR distributions and increased transposon activity .

Effective methodologies include:

  • ChIP-seq analysis: Using SPT23 antibodies to immunoprecipitate chromatin followed by sequencing identifies binding at transposon-related sequences. This approach reveals how SPT23 directly interacts with transposon elements.

  • Differential binding analysis: Comparing SPT23 binding patterns between normal conditions and stress conditions (particularly heat shock) reveals condition-specific regulation of transposons.

  • Integration with LTR-amplicon sequencing: LTR-amplicon sequencing data can be correlated with ChIP-seq results to provide comprehensive insights into how SPT23 binding affects transposon distribution and activity patterns.

  • Protein complex identification: Co-immunoprecipitation using SPT23 antibodies can identify interactions with transposon-encoded proteins or transcription factors that mediate transposon regulation.

These approaches help establish the mechanistic basis for observations that SPT23 deletion affects both transposon activity patterns and thermal tolerance .

What methodological considerations are important when using SPT23 antibodies for studying lipid regulation?

SPT23 functions as a key transcriptional regulator of OLE1, which determines unsaturated fatty acid levels in cell membranes. Research has established that total unsaturated lipid acid contents in cell membranes are negatively associated with SPT23 expression levels, with deletion strains showing altered ULA content .

When designing experiments to study this regulatory pathway:

  • Membrane preparation protocols: Careful isolation of membrane fractions is essential since SPT23 processing occurs at the membrane. Standard protocols include:

    • Cell disruption by glass bead homogenization

    • Differential centrifugation to separate membrane fractions

    • Careful buffer selection to maintain membrane integrity

  • Correlative experimental design: Effective studies correlate:

    • SPT23 processing status (detected by immunoblotting)

    • OLE1 expression levels (by RT-qPCR)

    • Membrane fatty acid composition (by gas chromatography)

  • Time-course considerations: Since SPT23 regulation responds dynamically to temperature and lipid availability, time-course experiments are essential to capture the full regulatory picture.

  • Subcellular fractionation quality control: When separating membrane and nuclear fractions to track p120 and p90 forms, fraction purity should be verified with:

    • ER markers (for membrane fractions)

    • Nuclear markers (for nuclear fractions)

    • Western blotting for SPT23 in both fractions

These methods have revealed that SPT23 deletion strains show distinct changes in thermal tolerance correlated with altered lipid composition .

What are optimal Western blot protocols for detecting SPT23 with antibodies?

Effective Western blot detection of SPT23 requires optimized protocols that account for its membrane association, processing dynamics, and molecular weight:

Protocol StepRecommendationRationale
Sample preparationInclude protease inhibitorsPrevents artificial processing
Lysis buffer50mM Tris pH 7.5, 150mM NaCl, 1% NP-40, 10% glycerol, 1mM EDTAEfficient extraction of membrane-associated proteins
Gel percentage8% acrylamide or 4-15% gradientBetter separation of high molecular weight proteins
TransferLow current overnight to PVDFEfficient transfer of high MW proteins
Blocking5% non-fat milk in TBST, 1 hourReduces background
Primary antibody1:1000 dilution, overnight at 4°COptimal signal-to-noise ratio
Detection systemHRP-conjugated secondary with ECLStandard detection method

Essential controls for SPT23 Western blots:

  • Positive control: Lysate from cells overexpressing SPT23

  • Negative control: Lysate from SPT23 deletion strain

  • Processing control: Sample treated with proteasome inhibitors

  • Loading control: Constitutively expressed protein (e.g., tubulin)

For optimal visualization of both p120 and p90 forms, gradient gels and extended run times improve band separation, while membrane type (PVDF rather than nitrocellulose) and transfer conditions should be optimized for high molecular weight proteins.

What are the most effective immunoprecipitation protocols for SPT23?

Optimized immunoprecipitation (IP) protocols for SPT23 must account for its membrane association and processing dynamics:

  • Cross-linking IP for transient interactions:

    • Formaldehyde cross-linking (1% for 10 minutes)

    • Sonication to shear chromatin and solubilize proteins

    • IP with SPT23 antibodies

    • Reverse cross-linking before analysis

  • Native IP for stable complexes:

    • Cell disruption by glass bead homogenization

    • Membrane solubilization with mild detergents (1% Digitonin or 0.5% NP-40)

    • Addition of glycerol (10%) to stabilize complexes

    • Incubation with SPT23 antibodies pre-bound to Protein A/G beads

  • Two-step IP for studying processing dynamics:

    • Initial IP for total SPT23

    • Elution under native conditions

    • Secondary IP with form-specific antibodies

    • Analysis of processing-dependent interactions

Buffer optimization is crucial, with key components including:

  • pH 7.5-8.0 to maintain native protein structure

  • Protease inhibitors to prevent artificial processing

  • Reducing agents (DTT or β-mercaptoethanol) to maintain protein structure

  • Salt concentration (150-300mM NaCl) adjusted for desired stringency

These protocols enable detailed study of SPT23 processing dynamics and interaction partners under different stress conditions.

How should SPT23 antibodies be used in chromatin immunoprecipitation experiments?

Chromatin immunoprecipitation (ChIP) using SPT23 antibodies requires specialized protocols:

  • Cross-linking optimization:

    • 1% formaldehyde for 10-15 minutes at room temperature

    • Addition of glycine (125mM final) to quench

    • Optional dual cross-linking with DSG before formaldehyde for improved capture

  • Chromatin preparation:

    • Cell wall digestion with zymolyase for yeast samples

    • Sonication to achieve 200-500 bp fragments

    • Verification of fragmentation by agarose gel electrophoresis

  • Immunoprecipitation:

    • Pre-clearing with Protein A/G beads

    • Incubation with SPT23 antibodies (2-5 μg)

    • Sequential washes with increasing stringency

    • Elution and reverse cross-linking

  • Quality control measures:

    • Input control (non-immunoprecipitated chromatin)

    • IgG control (non-specific antibody)

    • Positive control regions (known SPT23 binding sites, e.g., OLE1 promoter)

    • qPCR validation of enrichment before sequencing

  • Data analysis approaches:

    • Peak calling with appropriate algorithms

    • Motif analysis for binding site preferences

    • Integration with gene expression data

    • Comparison of binding profiles under different conditions

Specialized ChIP-seq analysis focusing on transposon binding sites can reveal how SPT23 regulates transposon activity, complementing findings from LTR-amplicon sequencing that show SPT23 deletion affects LTR distribution patterns .

What approaches help troubleshoot non-specific binding with SPT23 antibodies?

Non-specific binding is a common challenge when working with SPT23 antibodies. Systematic troubleshooting approaches include:

  • Antibody optimization:

    • Titrate antibody concentration to find optimal signal-to-noise ratio

    • Test multiple antibodies targeting different epitopes

    • Consider affinity-purified antibodies for improved specificity

    • Pre-absorb antibody with yeast lysate from SPT23 deletion strain

  • Blocking improvements:

    • Test different blocking agents (BSA, non-fat milk, commercial blockers)

    • Extend blocking time (2 hours to overnight)

    • Add 0.1-0.5% Tween-20 to reduce hydrophobic interactions

  • Wash optimization:

    • Increase salt concentration (150mM → 300-500mM NaCl)

    • Add mild detergents (0.1-0.5% Triton X-100)

    • Extend wash times and increase wash repetitions

  • Sample preparation refinements:

    • Ensure complete cell lysis

    • Pre-clear lysates by centrifugation

    • Filter lysates to remove aggregates

    • Include competitors for common non-specific interactions

For Western blots specifically:

  • Run gradient gels for better resolution

  • Transfer high molecular weight proteins at lower voltage for longer time

  • Use membrane with appropriate binding capacity (PVDF for higher binding)

  • Consider signal enhancement systems for weak specific signals

Validation experiments to confirm specificity include peptide competition assays, signal absence in SPT23 deletion strains, and comparing multiple antibodies targeting different epitopes.

How can SPT23 antibodies be used to investigate protein-protein interactions in stress response pathways?

SPT23 antibodies enable detailed analysis of protein-protein interactions during stress responses through several advanced approaches:

  • Quantitative co-immunoprecipitation:

    • Immunoprecipitate SPT23 using validated antibodies

    • Identify co-precipitating proteins by mass spectrometry

    • Compare interaction profiles under normal vs. stress conditions

    • Quantify changes in interaction strength using SILAC or TMT labeling

  • Proximity-dependent labeling:

    • Express SPT23 fused to BioID or APEX2

    • Validate fusion protein localization using SPT23 antibodies

    • Identify proximal proteins during stress response

    • Confirm key interactions by standard co-IP with SPT23 antibodies

  • Sequential ChIP (ChIP-reChIP):

    • First ChIP with SPT23 antibodies

    • Second ChIP with antibodies against suspected partners

    • Identifies genomic loci where both proteins co-localize

    • Reveals functional transcriptional complexes

  • Immunofluorescence co-localization:

    • Double immunostaining for SPT23 and interaction partners

    • Super-resolution microscopy for precise spatial relationships

    • Quantitative co-localization analysis

    • Correlation with functional outcomes

Research has demonstrated that SPT23 processing and activity are regulated in response to heat stress, with deletion strains showing improved thermal tolerance . These methods can reveal the protein interaction networks that underlie this regulatory relationship and connect it to changes in transposon activity and lipid composition.

What methods can quantify changes in SPT23 expression and localization during stress?

Accurate quantification of SPT23 expression and localization during stress responses requires multimodal approaches:

  • Quantitative Western blot analysis:

    • Time-course sampling during stress exposure

    • Separate quantification of p120 and p90 forms

    • Normalization to loading controls

    • Calculation of p90/p120 ratio as processing indicator

  • Subcellular fractionation coupled with immunoblotting:

    • Isolation of membrane and nuclear fractions

    • Western blot analysis with SPT23 antibodies

    • Quantification of distribution between compartments

    • Correlation with stress intensity and duration

  • Quantitative immunofluorescence microscopy:

    • Fixed-cell immunostaining at defined stress timepoints

    • Confocal imaging with consistent acquisition parameters

    • Automated image analysis for nuclear/cytoplasmic ratio

    • Single-cell quantification to capture population heterogeneity

  • Flow cytometry:

    • Fixed and permeabilized cells

    • SPT23 antibody labeling with fluorescent secondary antibodies

    • High-throughput quantification of thousands of cells

    • Population statistics for response heterogeneity

When applying these methods to heat stress studies, researchers have observed that SPT23 processing dynamics correlate with thermal tolerance, and that deletion strains show higher survival rates under heat stress conditions . These quantitative approaches help establish the mechanistic basis for these observations.

How do researchers use SPT23 antibodies to correlate molecular changes with phenotypic outcomes?

Connecting molecular changes in SPT23 to phenotypic outcomes requires integrated experimental approaches:

  • Correlation analysis workflow:

    • Measure SPT23 processing status via immunoblotting

    • Determine lipid composition by analytical chemistry

    • Assess thermal tolerance through survival assays

    • Perform statistical correlation analysis between these parameters

  • Genetic complementation studies:

    • Create SPT23 variants with mutations in key domains

    • Express in SPT23 deletion background

    • Analyze protein expression and processing with antibodies

    • Measure restoration of wild-type phenotypes

  • Time-resolved analysis:

    • Track SPT23 processing during stress time course

    • Monitor downstream effects on target gene expression

    • Measure physiological parameters at matching timepoints

    • Establish cause-effect relationships through temporal sequence

  • Dose-response experiments:

    • Expose cells to varying stress intensities

    • Quantify SPT23 processing at each level

    • Measure corresponding phenotypic outcomes

    • Determine threshold levels for response activation

Research has established that SPT23 expression levels are negatively correlated with thermal tolerance, with deletion strains showing higher survival rates, biomass, and ethanol production under heat stress . Additionally, total unsaturated lipid acid contents in cell membranes are negatively associated with SPT23 expression levels . These correlative approaches help establish causal relationships between molecular mechanisms and physiological outcomes.

What high-throughput screening approaches can utilize SPT23 antibodies?

SPT23 antibodies enable high-throughput screening approaches for identifying regulators of stress response pathways:

  • Automated immunofluorescence microscopy:

    • 96 or 384-well format cell culture

    • Robotic fixation and immunostaining with SPT23 antibodies

    • Automated image acquisition and analysis

    • Quantification of SPT23 processing and localization

  • ELISA-based screening:

    • Cellular lysate preparation in microplate format

    • Capture with one SPT23 antibody

    • Detection with second antibody against different epitope

    • Quantification of total or processed SPT23 levels

  • AlphaScreen/AlphaLISA technology:

    • Bead-based homogeneous assay format

    • No separation or washing steps

    • High sensitivity for protein detection

    • Suitable for 384 or 1536-well format

  • Flow cytometry screening:

    • Single-cell analysis of SPT23 levels/localization

    • Multi-parameter correlation with other cellular markers

    • Fast analysis of thousands of cells per second

    • FACS sorting for extreme phenotypes

These approaches can be applied to screen:

  • Chemical libraries for modulators of SPT23 processing

  • Genetic perturbation libraries (CRISPR, RNAi)

  • Environmental condition arrays

  • Synthetic genetic interaction screens

The identification of SPT23 as a key regulator of thermal tolerance through eQTL analysis demonstrates the value of systematic screening approaches . High-throughput antibody-based methods extend these capabilities to functional and mechanistic studies.

How can researchers integrate SPT23 antibody data with other "omics" datasets?

Integrated multi-omics approaches provide comprehensive understanding of SPT23 function:

  • ChIP-seq and RNA-seq integration:

    • Map SPT23 binding sites genome-wide using ChIP-seq

    • Correlate with gene expression changes using RNA-seq

    • Identify direct versus indirect regulatory targets

    • Construct gene regulatory networks

  • Proteomics integration:

    • Quantify SPT23 interaction partners by IP-MS

    • Correlate with global proteome changes

    • Identify post-translational modifications

    • Map protein complex dynamics

  • Lipidomics correlation:

    • Measure membrane lipid composition changes

    • Associate with SPT23 processing status

    • Connect with thermal tolerance phenotypes

    • Establish mechanistic links

  • Transposon activity analysis:

    • Combine ChIP-seq data with LTR-amplicon sequencing

    • Identify direct SPT23 binding to transposon elements

    • Correlate with changes in transposon distribution

    • Establish regulatory relationships

Research using LTR-amplicon sequencing has demonstrated that SPT23 deletion affects transposon activities, with deletion strains showing lower richness and higher evenness in LTR distributions . Integration of these datasets with SPT23 binding profiles can reveal the mechanisms underlying this observation.

A regression analysis incorporating multiple data types revealed that the relative weight of SPT23's direct transcriptional influence versus transposon-induced effects is approximately 4:3 , highlighting the value of integrated multi-omics approaches.

What are the current limitations in SPT23 antibody research?

Despite their utility, current SPT23 antibody applications face several limitations:

  • Form-specific detection challenges: Distinguishing between the p120 and p90 forms often requires careful optimization of electrophoretic conditions and antibody selection.

  • Species cross-reactivity limitations: Most available antibodies are optimized for S. cerevisiae SPT23 and may not cross-react with homologs in other fungal species.

  • Post-translational modification detection: Few antibodies are available that specifically recognize modified forms of SPT23.

  • Quantification standardization: Lack of universal standards for quantitative comparisons across different studies.

  • Temporal resolution limitations: Current antibody-based methods provide snapshots rather than continuous monitoring of SPT23 dynamics.

Future development of SPT23 antibodies with enhanced specificity for different forms, modifications, and improved cross-species reactivity would advance research in this field.

What are the future directions for SPT23 antibody applications in research?

Emerging technologies and approaches promise to expand SPT23 antibody applications:

  • Single-cell protein analysis: Integration of SPT23 antibodies with microfluidic and droplet-based single-cell proteomics methods.

  • In vivo imaging: Development of intrabodies or nanobodies against SPT23 for live-cell imaging of processing dynamics.

  • Spatial proteomics: Application of multiplexed antibody-based imaging methods to map SPT23 localization relative to the entire proteome.

  • Engineered biosensors: Creation of conformation-sensitive antibody fragments that report on SPT23 processing states in living cells.

  • Therapeutic applications: Exploration of SPT23 pathway modulators in fungal pathogens, building on understanding of its role in stress responses.

The established importance of SPT23 in thermal tolerance mechanisms suggests these advanced antibody applications could yield insights relevant to both basic yeast biology and biotechnological applications where stress tolerance is critical.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.